|-- Q3 2013 Press Release:||October 31, 2013 at 7:00 a.m. ET|
|-- Q3 2013 Conference Call:||October 31, 2013 at 8:30 a.m. ET|
|-- Domestic Dial In Number:||877-407-8037|
|-- International Dial In Number:||201-689-8037|
|-- Conference ID #||421882|
The conference call will also be webcast live and can be accessed at www.incyte.com under Investor Relations, Events and Webcasts.About Incyte Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary small molecule drugs for oncology and inflammation. For additional information on Incyte, please visit the Company's web site at www.incyte.com.